tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Bicycle Therapeutics initiated with a Hold at Truist
PremiumThe FlyBicycle Therapeutics initiated with a Hold at Truist
2M ago
Buy Rating for Bicycle Therapeutics: Strong Upside Potential Amid Clinical and Financial Developments
Premium
Ratings
Buy Rating for Bicycle Therapeutics: Strong Upside Potential Amid Clinical and Financial Developments
3M ago
Bicycle Therapeutics price target raised to $12 from $10 at Citizens JMP
Premium
The Fly
Bicycle Therapeutics price target raised to $12 from $10 at Citizens JMP
3M ago
Bicycle Therapeutics reports Q3 EPS (85c), consensus ($1.07)
PremiumThe FlyBicycle Therapeutics reports Q3 EPS (85c), consensus ($1.07)
3M ago
Bicycle Therapeutics Expands Board with New Appointments
Premium
Company Announcements
Bicycle Therapeutics Expands Board with New Appointments
5M ago
Bicycle Therapeutics price target lowered to $10 from $22 at Citizens JMP
Premium
The Fly
Bicycle Therapeutics price target lowered to $10 from $22 at Citizens JMP
6M ago
Bicycle Therapeutics files $500M mixed securities shelf
PremiumThe FlyBicycle Therapeutics files $500M mixed securities shelf
6M ago
Bicycle Therapeutics: Strategic Cost Reduction and Program Advancements Justify Buy Rating
Premium
Ratings
Bicycle Therapeutics: Strategic Cost Reduction and Program Advancements Justify Buy Rating
6M ago
Bicycle Therapeutics Appoints Charles Swanton to Board
Premium
Company Announcements
Bicycle Therapeutics Appoints Charles Swanton to Board
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100